Clinical Trial Update: Comparison in Efficacy and Safety Between Interferon Alfacon-1 Alone and Concomitant Dosing With Ribavirin for the Treatment of Hepatitis C [Phase 3]

View source ↗

Summary

Phase 3 trial comparing interferon alfacon-1 alone versus concomitant ribavirin dosing for hepatitis C; the study evaluated efficacy and safety and has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Interferon Alfacon-1 (interferon alfacon-1)
• Ribavirin (ribavirin)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Hepatitis C | Phase 3 | Status: COMPLETED